Vaccine Summit London
The O2 *London, UK Visit the Venue to read more
Now in its third year, this international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of vaccine development and vaccinations. Using a multi-professional and inter-specialty approach this event offers plenty of opportunity for networking and debate, and will bring you up to date with current research and thinking.
This event has an open abstract session.
Abstracts can be submitted on any subject related to vaccines and vaccination
The Deadline for abstract submissions for oral presentation is July 20th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
Who Should Attend
Public and animal health scientists
Scientists developing, or with an interest in, new or enhanced vaccine adjuvants
Individuals interested in novel vaccine delivery systems
Individuals establishing diagnostic assays for viruses.
Epidemiologists, virologists, immunologists, R&D, pre-clinical vaccinologists
Basic scientists, industrial experts, and clinicians with an interest in the science of viral co-infection.
Effect of oil adjuvants on integrity of foot-and-mouth disease virus vaccine antigens
Dr. Michiel M. Harmsen, Scientist, Central Veterinary Institute Wageningen UR, Division Virology, Lelystad, The Netherlands
Therapuetic use of vaccine for treatment of chronic hepatitis B: from bench to bedside
Dr. Sheikh Mohamad Fazle Akbar, MBBS, MD, PhD, Principal Investigator, Toshiba General Hospital, Tokyo, Japan
Synthetic biologic approaches and technologies for inducing an immune response against tumor antigens
Dr Jonathan Lewis, Ziopharm Oncology, Boston, United States
Integration of biology and mathematical modelling towards a better understanding of pathogen behaviour and rational design of improved bacterial vaccines.
Dr Piero Mastroeni, Reader in Infection and Immunity, University of Cambridge, United Kingdom
Dengue virus NS1protein as a vaccine target: risks and benefits
Dr Jaime Henrique Amorim, Laboratoty for Vaccine Development, Biomedical Sciences Institute, University of São Paulo, Brazil.
Oncolytic activity of attenuated Measles virus against mesothelioma
Dr Jean-François FONTENEAU, Chargé de recherche INSERM, INSERM UMR892, CNRS UMR6299, Institut de Recherche en Santé de l'Université de Nantes, France
Oral vaccines for the control of poultry diseases.
Professor Anthony Amaechi ATTAMA, Department of Pharmaceutics, University of Nigeria, Nsukka, Nigeria
Investigation of antibodies generated in response to vaccination with a HCMV gB subunit vaccine
Dr Gary R McLean, Imperial College London & London Metropolitan University, London, UK
Why do parents who usually vaccinate their children hesitate or refuse? General good vs. individual risk
Dr Anat Gesser-Edelsburg, Head of Health Promotion Department, School of Public Health, University of Haifa, Israel
HIV-1 vaccine: Where have we gone wrong?
Dr Cynthia L. Bristow, Chief Executive Officer, Alpha-1 Biologics, New York , USA
Dr Athleen Hefferon, University of Toronto, Ont., Canada
Mucosal tolerance in preventing recurrent heart disease
Emeritus Professor Vijay Kakkar, President, Thrombosis Research Institute, London, UK
Patient Safety: Using technology to select the right vaccine, right person, right schedule.
Dr Adrienne Willcox, Health Team Ltd., Glos, UK
Russian vaccines against especially dangerous bacterial pathogens
Dr Valentina A Feodorova, Saratov, Russia
Overview of assays for influenza vaccines immunology evaluation and correlates of protection
Professor Emanuele Montomoli, Dept. of Molecular and Developmental Medicine, University of Siena, Italy
Evolutionary Therapy: Immunotherapy As Personalized Medicine
Dr Ravi A. Madan, Clinical Director, Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, USA
Mr Muhammad Hoque, University of KwaZulu-Natal (Westville Campus), Durban, South Africa
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Cineworld: The O2